The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
951
June 23, 1995
View Complete Issue         Table of Contents 2019 
Issue 951
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Varicella Vaccine
June 23, 1995 (Issue: 951)
A live attenuated varicella vaccine (Varivax - Merck) has been approved for marketing by the US Food and Drug Administration. The Oka/Merck strain used in the vaccine is attenuated by passage in human and embryonic guinea pig cell cultures.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 951
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.